These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6265230)

  • 1. Prostacyclin prevents ischemia-induced increase of lactate and cyclic AMP in ischemic myocardium.
    Rösen R; Rösen P; Ohlendorf R; Schrör K
    Eur J Pharmacol; 1981 Feb; 69(4):489-91. PubMed ID: 6265230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of post-ischemic ventricular recovery by low concentrations of prostacyclin in isolated working rat hearts: dependency on concentration, ischemia duration, calcium and relationship to myocardial energy metabolism.
    Karmazyn M; Neely JR
    J Mol Cell Cardiol; 1989 Mar; 21(3):335-46. PubMed ID: 2664190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of prostacyclin on the cardiac functions and energy metabolism in the perfused rat heart].
    Takeuchi S
    Hokkaido Igaku Zasshi; 1985 May; 60(3):355-67. PubMed ID: 3894189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGI2 inhibits ischemia-induced platelet activation and prevents myocardial damage by inhibition of catecholamine release from adrenergic nerve terminals. Evidence for cAMP as common denominator.
    Schrör K; Addicks K; Darius H; Ohlendorf R; Rösen P
    Thromb Res; 1981 Jan 1-15; 21(1-2):175-80. PubMed ID: 6262944
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro.
    Schrör K; Link HB; Rösen R; Klaus W; Rösen P
    Eur J Pharmacol; 1980 Jun; 64(4):341-8. PubMed ID: 6156077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of prostaglandin-mediated cyclic AMP formation in protein kinase C-dependent secretion of atrial natriuretic peptide in rat cardiomyocytes.
    Church DJ; Van der Bent V; Vallotton MB; Lang U
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):217-25. PubMed ID: 7945244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
    Schrör K; Rösen P
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):101-3. PubMed ID: 218118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hypoxic effect of prostacyclin.
    Nikolov R; Nikolova M; Miyares C; Milanova D
    Methods Find Exp Clin Pharmacol; 1982; 4(4):211-9. PubMed ID: 6750283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prostaglandins I2 (prostacyclin) and F2 alpha on function, energy metabolism, and calcium uptake in ischaemic/reperfused hearts.
    Karmazyn M; Tani M; Neely JR
    Cardiovasc Res; 1993 Mar; 27(3):396-402. PubMed ID: 8490938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the protective effect of prostacyclin in acute myocardial ischemia.
    Ogletree ML; Lefer AM; Smith JB; Nicolaou KC
    Eur J Pharmacol; 1979 Jun; 56(1-2):95-103. PubMed ID: 467518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of defibrotide in acute myocardial ischemia in the cat.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G
    Thromb Res; 1985 Apr; 38(1):71-81. PubMed ID: 3890260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of defibrotide in acute lethal and nonlethal myocardial ischemia in the cat.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G; Berti F
    Haemostasis; 1986; 16 Suppl 1():18-25. PubMed ID: 3519380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin stimulation of dog arterial cyclic AMP levels.
    Miller OV; Aiken JW; Hemker DP; Shebuski RJ; Gorman RR
    Prostaglandins; 1979 Dec; 18(6):915-25. PubMed ID: 232764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bunazosin, a selective alpha 1-adrenergic blocking agent, on myocardial energy metabolism in ischemic dog heart.
    Yoshida R; Ichihara K; Abiko Y
    Jpn J Pharmacol; 1990 Aug; 53(4):435-41. PubMed ID: 1976843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prostacyclin on the severity of ischaemic injury in rabbit hearts subjected to coronary ligation.
    Edlund A; Sahlin K; Wennmalm A
    J Mol Cell Cardiol; 1986 Oct; 18(10):1067-76. PubMed ID: 3537319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of prostaglandins in the regulation of coronary blood flow.
    Schrör K
    Basic Res Cardiol; 1981; 76(3):239-49. PubMed ID: 6268056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
    Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W
    J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin increases cAMP in coronary arteries.
    Kukovetz WR; Holzmann S; Wurm A; Pöch G
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):469-76. PubMed ID: 231612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin: effects on cyclic AMP in bone cells.
    Robin JC; Brown MJ; Weinfeld N; Dziak R
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):43-9. PubMed ID: 6276954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGI2 prevents ischemia-induced alterations in cardiac catecholamines without influencing nerve-stimulation-induced catecholamine release in nonischemic conditions.
    Schrör K; Darius H; Addicks K; Köster R; Smith EF
    J Cardiovasc Pharmacol; 1982; 4(5):741-8. PubMed ID: 6182404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.